Vertex’s effort to provide fertility support services to those on government insurance programs who want to take the ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

Vertex Securities Limited is an India-based company, which offers comprehensive brokerage services across various financial segments, including equity, equity derivatives, currency derivatives ...

The No. 1 seeds Florida Gators and Duke Blue Devils passed their respective tests in the Elite Eight round of the 2025 NCAA ...

A group of cystic fibrosis patients could be denied access to a cutting-edge therapy after manufacturer Vertex refused to submit data to cost-effectiveness body NICE. The manufacturer's decision ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

KLP Kapitalforvaltning AS bought a new position in shares of Atmus Filtration Technologies Inc. (NYSE:ATMU – Free Report) during the fourth quarter, according to the company in its most recent 13F ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Finland is the happiest nation in the world, according to a new report that shows the UK lagging behind in 23rd place. People living in Finland rated their life satisfaction 7.7/10 on average ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.